Cargando…
Low Dose Carbon Monoxide Exposure in Idiopathic Pulmonary Fibrosis Produces a CO Signature Comprised of Oxidative Phosphorylation Genes
Compelling preclinical studies indicate that low-dose carbon monoxide (CO) abrogates experimental lung fibrosis. We recently reported the results of a multicenter, double-blinded, clinical trial of inhaled CO in patients with idiopathic pulmonary fibrosis (IPF). Identifying no significantly changes...
Autores principales: | Casanova, Nancy, Zhou, Tong, Gonzalez-Garay, Manuel L., Rosas, Ivan O., Goldberg, Hilary J., Ryter, Stefan W., Collard, Harold R., El-Chemaly, Souheil, Flaherty, Kevin R., Hunninghake, Gary M., Lasky, Joseph A., Lederer, David J., Machado, Roberto F., Martinez, Fernando J., Noth, Imre, Raghu, Ganesh, Choi, Augustine M. K., Garcia, Joe G. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794274/ https://www.ncbi.nlm.nih.gov/pubmed/31615996 http://dx.doi.org/10.1038/s41598-019-50585-3 |
Ejemplares similares
-
Carbon monoxide: present and future indications for a medical gas
por: Ryter, Stefan W., et al.
Publicado: (2013) -
Heme oxygenase-1 and carbon monoxide in pulmonary medicine
por: Slebos, Dirk-Jan, et al.
Publicado: (2003) -
Shorter telomere length following lung transplantation is associated with clinically significant leukopenia and decreased chronic lung allograft dysfunction-free survival
por: Courtwright, Andrew M., et al.
Publicado: (2020) -
Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
por: Podolanczuk, Anna J., et al.
Publicado: (2022) -
Heme oxygenase/carbon monoxide signaling pathways: Regulation and functional significance
por: Ryter, Stefan W., et al.
Publicado: (2002)